This September marks 40 years since the birth of the generic drug industry in the United States. They saved Americans nearly $450 billion last year alone. But all is not well in the industry \u2014\xa0big players are leaving, and drug shortages are common. Will we still be able to depend on affordable, high-quality generics in the future? Also: new rules on bank mergers, and a disagreement between the stock market and bond market.